Your search returned 5 results.

Sort
Results
1.
Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials. MedStar authors:
  • Weissman, Neil J
PMID:
  • 27888609
Year: 2017
Citation:
  • Obesity. 25(1):39-44, 2017 Jan
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Fain R, Hall N, Shanahan WR, Smith SR, Weissman NJ
2.
Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals. MedStar authors:
  • Sharma, Susmeeta
PMID:
  • 33507248
Year: 2021
Citation:
  • Journal of Clinical Endocrinology & Metabolism. 106(5):1501-1515, 2021 04 23.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Grewal S, Gubbi S, McGlotten R, Muniyappa R, Nieman LK, Sharma ST
3.
Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. MedStar authors:
  • Weissman, Neil J
PMID:
  • 22421927
Year: 2012
Citation:
  • Obesity. 20(7):1426-36, 2012 Jul.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Anderson CM, Fidler MC, O'Neil PM, Raether B, Sanchez M, Shanahan WR, Smith SR, Weissman NJ, Zhang J
4.
Echocardiographic assessment of cardiac valvular regurgitation with lorcaserin from analysis of 3 phase 3 clinical trials. MedStar authors:
  • Weissman, Neil J
PMID:
  • 23661689
Year: 2013
Citation:
  • Circulation. Cardiovascular imaging. 6(4):560-7, 2013 Jul.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Anderson CM, Koch GG, Sanchez M, Shanahan WR, Smith SR, Weissman NJ
5.
Neuropsychiatric safety with liraglutide 3.0mg for weight management: results from randomized controlled phase 2 and 3a trials. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28386912
Year: 2017
Citation:
  • Diabetes, Obesity & Metabolism. 19(11):1529-1536, 2017 Nov.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Astrup A, Brett J, Cancino A, Kushner R, Lau DC, O'Neil PM, Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups, Wadden TA, Wilding JP
Pages

Powered by Koha